Product Description
Sunscreening Agent (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02803034?term=NCT02803034&rank=1)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: N/A
Route of Administration: Topical,Transdermal
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Elanco Animal Health
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
SPF Assay | N/A |
Completed |
Sunburn |
2017-01-13 |
|
NCT02995122 | N/A |
Completed |
Sunburn |
2017-01-06 |
|
SPF Assay 201/2016 | N/A |
Completed |
Sunburn |
2016-11-03 |
|
SPF Assay 203/2016 | N/A |
Completed |
Sunburn |
2016-10-19 |